The occurrence of
iodine-induced
hyperthyroidism (IIH) has been reported after
iodine supplementation from clinics and hospitals, but not following an epidemiologic survey. We studied the prevalence of thyroid derangement in a population following
iodine supplementation. One yr after more than 75% of the population had been consuming 40 ppm
iodized salt; information regarding history of
endemic goiter and
iodized salt production, distribution, consumption and monitoring were collected in four cities of the Islamic Republic of Iran. A total of 6048 subjects were randomly selected. All subjects were assessed for size of
goiter, and urinary
iodine and serum T4, T3, TSH,
anti-thyroglobulin and anti-thyroperoxide were measured. Before
iodine supplementation, all four cities were areas of
endemic goiter. The rate of household consumption of
iodized salt was 50, 75 and 90% in 1994, 1995 and 1996, respectively. Ninety-one percent of the
salt samples contained 15-55 ppm
iodide. Total
goiter rate was 57, 62 and 68%; median urinary
iodine was 188, 197 and 190 microg/l in the age groups of 6-18, 19-40 and >40 yr, respectively. Prevalence of clinical and subclinical
hyperthyroidism was 0.34 and 0.41 and those of clinical and subclinical
hypothyroidism were 0.51 and 1.07%, respectively. Nine point eight and 18% in the 19-40 yr age group and 17.6 and 25.6% in >40 yr old subjects had positive anti-thyroperoxidase and
anti-thyroglobulin, respectively. This systemic epidemiologic study in an
iodine deficient population showed that, following a well-executed
iodine supplementation program, the occurrence of IIH is rare.